MERS and SARS News Releases

MERS Antibodies Produced in Cattle Safe, Treatment Well Tolerated in Phase 1 Trial
January 9, 2018

An experimental treatment developed from cattle plasma for Middle East respiratory syndrome (MERS) coronavirus infection shows broad potential, according to a small clinical trial led by National Institutes of Health scientists and their colleagues. The treatment, SAB-301, was safe and well tolerated by healthy volunteers, with only minor reactions documented.

NIH Scientists and Colleagues Successfully Test MERS Vaccine in Monkeys and Camels
August 19, 2015

​National Institutes of Health scientists and colleagues report that an experimental vaccine given six weeks before exposure to Middle East respiratory syndrome coronavirus (MERS-CoV) fully protects rhesus macaques from disease.

Experimental MERS Vaccine Shows Promise in Animal Studies
July 28, 2015

A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.